Dual acting HIV inhibitors: integrated rational in silico design strategy

In silico pharmacophore and structure-based drug design guided by binding mode analysis and molecular dynamics simulations is an effective approach for identifying novel potent and selective inhibitors. Herein, we demonstrated a unique strategy for developing dual acting inhibitors against HIV-1 protease and reverse transcriptase via an integrated… (More)